- Description
- Reviews (0)
Description
Abiraterone Acetate IP 250 mg
Composition :
Each film coated tablets contain :
Abiraterone Acetate IP ……..250MG
EXCIPIENTS ………………………….qs
USE:
Prostate Cancer
In combination with prednisone for the treatment of metastatic castration-resistant prostate cancer. Efficacy determined based on substantially prolonged overall survival and radiographic progression-free survival in 2 randomized, double-blind, placebo-controlled phase 3 studies (COU-AA-301 and COU-AA-302).
In combination with prednisone for the treatment of high-risk metastatic castration-sensitive prostate cancer. Efficacy determined based on substantially prolonged overall survival compared with placebo in men with metastatic castration-sensitive prostate cancer and ≥2 high-risk factors associated with poor prognosis in the LATITUDE study
This medicine can harm an unborn baby or cause miscarriage.
Warnings
Abiraterone tablets should not be handled by a woman who is pregnant or who may become pregnant. This medicine can harm an unborn baby or cause miscarriage.
STORAGE: Store protected from light & moisture, at a temperature not exceeding 30 0C .Keep out of reach of children.
Reviews
There are no reviews yet.